On April 24, 2025, X4 Pharmaceuticals, Inc. announced a 1-for-30 reverse stock split of its common shares effective April 28, 2025, following approval by shareholders on April 17, 2025. The move aims to adjust the company's stock structure but does not affect the total number of authorized shares.